News
BLRX
3.165
+1.61%
0.050
Weekly Report: what happened at BLRX last week (0615-0619)?
Weekly Report · 4d ago
Weekly Report: what happened at BLRX last week (0608-0612)?
Weekly Report · 06/15 09:54
BioLineRx Earnings Call: Pipeline Momentum, Profit Squeeze
TipRanks · 06/09 00:01
Weekly Report: what happened at BLRX last week (0601-0605)?
Weekly Report · 06/08 09:51
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 06/04 12:05
JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)
TipRanks · 06/02 12:41
Analysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)
TipRanks · 06/02 12:41
Weekly Report: what happened at BLRX last week (0525-0529)?
Weekly Report · 06/01 09:54
BioLineRx (BLRX) Q1 2026 Earnings Transcript
NASDAQ · 05/29 18:36
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 05/27 21:05
BioLineRx Kicks Off GLIX1 Clinical Trial as Q1 2026 Loss Widens on Higher R&D Spend
TipRanks · 05/27 11:48
BioLineRx GAAP EPS of $0.00 beats by $1.04, revenue of $0.48M beats by $0.14M
Seeking Alpha · 05/27 11:08
BioLine Rx Q1 Sales $477.000K Beat $343.000K Estimate
Benzinga · 05/27 11:02
BioLineRx turns to Q1 FY26 net loss of USD 2.6 million; revenue rises 66.67% to USD 0.5 million
PUBT · 05/27 11:01
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire · 05/27 11:00
Here are the major earnings before the open Wednesday
Seeking Alpha · 05/26 22:00
BioLineRx Q1 2026 Earnings Preview
Seeking Alpha · 05/26 14:10
Options Volatility and Implied Earnings Moves This Week, May 26 – May 28, 2026
TipRanks · 05/25 11:00
Weekly Report: what happened at BLRX last week (0518-0522)?
Weekly Report · 05/25 09:56
BioLineRx and Hemispherian Showcase New GLIX1 Data Ahead of ASCO 2026 as First-in-Human GBM Trial Enrolls
TipRanks · 05/22 11:29
More
Webull provides a variety of real-time BLRX stock news. You can receive the latest news about Biolinerx through multiple platforms. This information may help you make smarter investment decisions.
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.